Midas Pharma and Capsulution sign cooperation contract

Midas Pharma GmbH and Capsulution NanoScience AG have set up a framework for long-term cooperation following feasibility studies on the application of the LBL Technology for the improved delivery of pharmaceutical substances.

Capsulution is a Berlin-based start-up in the field of tailor-made drug-delivery systems and other innovative life science products on the basis of so-called nanocapsules manufactured using its patent protected LBL Technology. The nano- and microcapsules can be manufactured in any desired size, according to application and endowed with practically any biochemical, electric, optical and magnetic properties.

Midas Pharma is an independent marketing and sales company, located in Ingelheim, that supports customers and manufacturing partners in all issues concerning pharmaceutical substances from manufacture through to registration.

The gives Midas has access to the innovative technology of the Berlin-based company in exchange for its expertise in the downstream areas of the pharmaceutical value chain.

Capsulution will be able to offer pharmaceutical companies additional services in all issues concerning the procurement of pharmaceutical substances, pharmaceutical contract manufacturing, international license projects or the creation of registration dossiers.